IN8bio, Inc. (INAB)
NASDAQ: INAB · Real-Time Price · USD
1.340
+0.010 (0.75%)
At close: Jul 13, 2026, 4:00 PM EDT
1.330
-0.010 (-0.75%)
After-hours: Jul 13, 2026, 5:21 PM EDT
IN8bio Market Cap
IN8bio has a market cap or net worth of $13.2 million as of July 13, 2026. Its market cap has increased by 77.36% in one year.
Market Cap
13.20M
Enterprise Value
-6.49M
1-Year Change
77.36%
Ranking
Category
Stock Price
$1.34
Market Cap Chart
Since the IPO on July 30, 2021, IN8bio's market cap has decreased from $187.55M to $13.20M, a decrease of -92.96%. That is a compound annual growth rate of -41.46%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 13, 2026 | 13.20M | -42.23% |
| Dec 31, 2025 | 22.84M | 22.52% |
| Dec 31, 2024 | 18.64M | -68.76% |
| Dec 29, 2023 | 59.67M | 5.43% |
| Dec 30, 2022 | 56.60M | -31.25% |
| Dec 31, 2021 | 82.33M | -56.10% |
| Jul 30, 2021 | 187.55M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Passage Bio | 14.66M |
| Tempest Therapeutics | 14.41M |
| Cocrystal Pharma | 13.93M |
| Lunai Bioworks | 13.33M |
| BioLineRx | 13.08M |
| Intensity Therapeutics | 12.92M |
| AEON Biopharma | 12.71M |
| Chemomab Therapeutics | 12.53M |